The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Dialysis for schizophrenia: review of clinical trials and implications for further research

Published Online:https://doi.org/10.1176/ajp.137.5.605

At least 67 schizophrenic patients have undergone dialysis for renal failure, without improvement in schizophrenic symptoms. Ninety-two nonuremic schizophrenic patients have received dialysis in nonblind studies; 22 improved, 21 improved partially, 47 showed no change, and 2 became worse. The authors point out factors other than dialysis that may affect outcome, including family respones and reduction in drug dose. They believe that until the results of current double-blind, sham- controlled trials are known, dialysis should not be prescribed as a treatment for schizophrenia.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.